Anjan Shah, MD
Pediatric Cardiology · Oklahoma City, OKNPI 1609847680
Payments from drug & device makers
What this record shows
13 manufacturers reported payments, led by Medtronic at 56.2% of the total. 2025 is the largest year on record at $4,456, more than ten times the $410 reported in 2019.
Across 75 payments — averaging $92.61 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$4K
- Abbott$2K
- Biosense Webster, Inc.$227
- E.r. Squibb & Sons, L.L.C.$134
- Irhythm Technologies, Inc.$74
- Abiomed$57
- plus $181 from 7 others
What the payments were for
- Travel & lodging$3,55451%
- Food & beverage$3,39249%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic(2 entities) | 34 | $3,905 |
| Abbott | 21 | $2,367 |
| Biosense Webster, Inc. | 2 | $227 |
| E.r. Squibb & Sons, L.L.C. | 3 | $134 |
| Irhythm Technologies, Inc. | 4 | $74 |
| Abiomed | 1 | $57 |
| Baxter Healthcare | 3 | $54 |
| Bardy Diagnostics, Inc. | 2 | $35 |
| Philips North America LLC | 1 | $32 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 1 | $18 |
| Johnson & Johnson | 1 | $15 |
| ANI Pharmaceuticals, Inc. | 1 | $14 |
| Silvergate Pharmaceuticals, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- AVEIR$1,758
- ARCTIC FRONT ADVANCE$144
- Carto 3$119
- Carto 3 System$109
- CAMZYOS$104
How this compares
Too few pediatric cardiology providers in Oklahomato place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EntrestoSacubitril/Valsartan | 20 | $14,921 |
| Digoxin | 12 | $591 |
| Spironolactone | 12 | $142 |
Paid to pharmacies, not to this prescriber.
Other pediatric cardiology in Oklahoma City
- Shashank BehereOklahoma City$4K
- Charles SperrazzaOklahoma City$4K
- Omar Abu AnzaOklahoma City$2K
- Subhrajit LahiriOklahoma City$2K
- Anas SalkiniOklahoma City$2K
- R EdensOklahoma City$1K
- Edward OverholtOklahoma City$173
- Sherri BakerOklahoma City$161
- Elizabeth MakilOklahoma City$147
- Arshid MirOklahoma City$142
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.